A Randomised Cross-over Study With Two 1-piece Urostomy Bags.
NCT ID: NCT00765388
Last Updated: 2014-03-11
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE4
27 participants
INTERVENTIONAL
2008-10-31
2009-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
A urostomy bag consists of an adhesive, which is attached to the skin around the stoma and a bag connected to the adhesive to collect the urine.
It is very important the standard is high on these products; otherwise the user (urostomy-patient) will experience lots of problems with the skin around the stoma.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
GAG Replacement vs URethral DIlAtatioN
NCT03861260
Use of Antibiotic Based Irrigation for Ureteroscopic Treatment of Urolithiasis
NCT06007352
A Pilot Clinical Investigation of the Efficacy and Safety of Uracyst® Versus Placebo in Patients With Interstitial Cystitis/Painful Bladder Syndrome.
NCT00527917
Preventing UTIs in Chronic Neurogenic Bladder Dysfunction (Mix Methods)
NCT02591901
Evaluation of Quality-of-Life Improvements Using UroShield Device
NCT06319352
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Both products are CE-marked, meaning that they are safe and approved in use for people with an urostomy.
Population 30 urostomy operated people from UK will participate in the trial. Only participants who normally use a flat 1-piece urostomy bag can participate. It is very important that the participants keep their normal use- and change pattern. Furthermore they need to be over 18 years old, have had the urostomy for more than 3 months, the size of the urostomy shall be between 15-55 mm, otherwise the bag will not fit them and then they should be able to handle the bags themselves and be willing to use the two products tested in the trial.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
SenSura Uro
The test product is a CE-marked non-sterile one-piece urostomy multi-chamber bag with the SenSura adhesive.
SenSura Uro
The test product is a CE-marked non-sterile one-piece urostomy multi-chamber bag with the SenSura adhesive.
hollister Uro
The comparator product is CE-marked and non-sterile and produced for urostomy operated. It is a flat one-piece urostomy product, Hollister Moderma Flex Urostomy beige, Cut-to-Fit Bag, flat adhesive
Hollister
The comparator product is CE-marked and non-sterile and produced for urostomy operated. It is a flat one-piece urostomy product, Hollister Moderma Flex Urostomy beige, Cut-to-Fit Bag, flat adhesive.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
SenSura Uro
The test product is a CE-marked non-sterile one-piece urostomy multi-chamber bag with the SenSura adhesive.
Hollister
The comparator product is CE-marked and non-sterile and produced for urostomy operated. It is a flat one-piece urostomy product, Hollister Moderma Flex Urostomy beige, Cut-to-Fit Bag, flat adhesive.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Be at least 18 years old,
* Be mentally and physically capable of signing the written consent form
* Be able to fill in the Case Report Form (questionnaire)
* Have an urostomy with a size between 15-55 mm.
* Have had the urostomy for 3 months or more,
* Use a 1-piece bag normally.
* Be able to handle the bag themselves (application and removal)
* Be willing to use Coloplast SenSura 1-piece bag
* Be willing to use Hollisters Moderma Flex, 1-piece bag
Exclusion Criteria
* Be a convex base plate user (i.e. a bowl-shaped adhesive which pushes the stoma forward)
* Need to use an ostomy belt
* Be currently suffering from any dermatologiacal problems, needing special treatment, in the peristomal area (investigator will evaluate skin according to a newly developed ostomy skin tool from Coloplast A/S)
* Being treated with chemo- or radiation therapy,
* Be hospitalized during study enrollment, or have a hospitalization or significant surgery planned during the 4-week study period, or
* Be pregnant or breast-feeding.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Coloplast A/S
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Carol Katte, Stoma Nurse
Role: STUDY_CHAIR
Ashford and St. Peters Hospital
Maureen Bridgland, Stoma Nurse
Role: PRINCIPAL_INVESTIGATOR
Royal Sussex County Hospital
Caroline Rudoni, Stoma Nurse
Role: PRINCIPAL_INVESTIGATOR
St. Georges Hospital
Theresa Bowles, Stoma Nurse
Role: PRINCIPAL_INVESTIGATOR
Clinical Research and Trials Unit (Norfolk & Norwich University Hospital, UK)
Michael Lynch, Surgeon
Role: PRINCIPAL_INVESTIGATOR
Colchester General Hospital
Sharon Fillingham, Nurse
Role: PRINCIPAL_INVESTIGATOR
UCLH
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
St. Peters Hospital
Chertsey, Surrey, United Kingdom
Caroline Rudoni
London, Tooting, United Kingdom
Maureen Bridgland
Brighton, , United Kingdom
Michael Lynch
Colchester, , United Kingdom
University of London Hospital
London, , United Kingdom
Theresa Bowles
Norwich, , United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
DK188OS
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.